On May 20, 2008, Merck settled for $58 million with 30 states alleging that Merck engaged in deceptive marketing tactics to promote Vioxx.[78] All its new television pain-advertisements must be vetted by the Food and Drug Administration and changed or delayed upon request until 2018.[79]